Dr David Krige | Head of Biomarkers
Immunocore Limited

Dr David Krige, Head of Biomarkers, Immunocore Limited

David got his PhD from the Royal Free Hospital, university of London. He joined Immunocore in 2014 and is currently the head of Biomarkers. He expertise is in drug discovery, with focus on oncology and inflammation.


Day 3 Oct 12th Immune Profiling @ 10:10

Developing effective biomarker strategies for advanced clinical development of Immune mobilising monoclonal TCRs against cancer (ImmTACs)

  • Sharing updates on the phase I/IIa clinical trials in advanced melanoma
  • Employing a unique biomarker strategy which allows for comprehensive analysis of markers within the tumour as well as the surroundings
  • Enhanced knowledge acquired regarding the biologic mechanisms and response rates

back to speakers